<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Practical 4</title>

    <!-- <link rel="stylesheet" href="./style.css"> -->
    <style>
        /* Practical 4 styles */

    #Prac4content{
        text-align: center;
    } 
    table,td,th{
    border: 1px solid black;
    border-collapse: collapse;
}
    th{
        background-color: lightgreen;
    }
    </style>
</head>
<body>
    <div id="Prac4content">
<!-- <img src="../../trash/prac4.jpg" alt="" srcset="">         -->
<table>
            <caption>
                Table 1. Stem Cell Comapanies Active in Ophthaimology
            </caption>
            <colgroup>
            <col span="1" style="background-color: lightblue;">
            <col span="1" style="background-color: lightgray;">
            <col span="1" style="background-color: lightcoral;">
            <col span="1" style="background-color: lightyellow;">
            </colgroup>
            <tr>
                <th>Company</th>
                <th>Collaborator(s)</th>
                <th>Cell Type</th>
                <th>Applications</th>
            </tr>
            <tr>
                <td>Advanced Cell
                    Technology Inc.
                    (ACT)</td>
                    <td>Oregon Health & Science
                        University (OHSU) <br>
                    <ul>
                        <li>Moorfields Eye Hosp</li>
                        <li>UCLA./Jules Stein</li>
                        <li>Wills Eye Hospital</li>
                        <li>Aberdeen Royal Infirm.</li>
                        <li>Bascom Palmer</li>
                    </ul>
                    </td>
                    <td>hESCs</td>
                    <td>
                        RPE cells for retinal
                        discases, including Dry
                        AMD NCTO| 34.4993.
                        and Stargardt's
                        NCTO1 34 5006
                        NCT01 469832</td>
            </tr>
            <tr>
                <td>AstraZeneca</td>
                    <td>Univ. College London (UCL)</td>
                    <td>hESCs</td>
                    <td>Diabetic Retinopathy</td>
            </tr>
            <tr>
                <td>Centecer/3& J
                    w/ IScience
                    Interventional</td>
                    <td><ul><li>Retina Institute of CA</li>
                        <li>Wills Eye Hospital</li>
                        </ul></td>
                    <td>Adult SCs
                        (CNTO 2746
                        from umbilical
                        cord fluid)</td>
                    <td>RPE cells for GA
                        (atrophic dry AMD)
                        NCTOI 226628</td>
            </tr>
            <tr>
                <td>Cell Cure
                    Neuros clences
                    </td>
                    <td>TEVA</td>
                    <td>hESCs</td>
                    <td>RPE cells for dry AMD</td>
            </tr>
            <tr>
                <td>CellSeed France
                    SARL                    
                    </td>
                    <td>FGK Clinical Reserach GmbH 
                    <ul><li>FGK Clinical Reserach GmbH</li></ul>
                    </td>
                    <td>oral mucosa
                        epithelial cells</td>
                    <td>CAOMECS* for
                        Corncal tissue repair in
                        those with limbal cell
                        deficiencies
                        NCT01489501</td>
            </tr>
            <tr>
                <td>Fundacion
                    Clinic per a la
                    Recerca
                    Biomedica
                    (Spain)
                    </td>
                    <td><ul>
                        <li>Hospital Clinic
                            Barcelona</li>
                        <li>Instituto Univ. Barraquer</li>
                        <li>Instituto de Microc iru gia
                            Ocular</li>
                    </ul></td>
                    <td>
                        sclerocomeal
                        progenitor cells
                        from the
                        limbus</td>
                    <td>Replacement of
                        damagod corneal cells
                        NCT01470573</td>
            </tr>
            <tr>
                <td>
                    General Hosp of
                    the Chinese
                    People's Armed
                    Police Force
                    (China)
                    </td>
                    <td></td>
                    <td>unknown</td>
                    <td>Optic Nerve Atrophy
                        Chi CTR-TNRC-11.001</td>
            </tr>
            <tr>
                <td>International
                    Stem Cell Corp.
                    (ISCO)
                    </td>
                    <td>CytoCor - 
                        <ul>
                            <li>Absorption Systems - US</li>
                            <li>
                                Sankara Nethralaya - India</li>
                            <li>
                                Automation Partnership -
                                UK</li>
                        </ul>
                        CytoRet â€¢ UC Irvine
                    </td>
                    <td>hpSCs <br><br><br><br><br>
                        hpSCs
                    </td>
                    <td>Corneal tissue for
                        transplantation into
                        degenerated corneas <br><br><br><br>
                        RPE cells and layered
                        retinal structures for
                        AMD</td>
            </tr>
        </table>
    </div>
</body>
</html>